Documente Academic
Documente Profesional
Documente Cultură
Hepatic Disorders:
Hepatitis/Cirrhosis
Objectives
Compare and contrast risk factors associated
with hepatitis and cirrhosis
Analyze the etiology and pathophysiology of
hepatitis and cirrhosis
Integrate diagnostic tests with etiology,
pathophysiology, and signs/symptoms of both
disorders
Formulate relevant prioritized nursing diagnoses
that address physical, pyschosocial, and learning
needs and evaluate nursing interventions
A Liver
B Hepatic vein
C Hepatic artery
D Portal vein
E Common bile duct
F Stomach
G Cystic duct
H Gallbladder
Pathophysiology
Largest organ
Metabolic functions
Bile synthesis
Hepatocytes
Bile secretion
Storage
Mononuclear phagocyte system
Kupffer cells
Phagocytic activity
Metabolic functions
Metabolism glucose
Protein
Fatty acids
Cholesterol
Other Functions
Immunologic
Blood storage
Plasma protein synthesis
Clotting
Storage of vitamins and minerals
Waste products of hemoglobin
Bile formation and secretion
Steroids and hormones
Ammonia
Drugs, ETOH, toxin metabolism
HEPATITIS
Pathophysiology
Inflammation
Hepatic cell necrosis
Proliferation/enlargement Kupffer cells
Cholestasis
Regeneration
10
11
Clinical Manifestations
Acute
Anorexia
N/V
RUQ pain
Bowel irregularity
Malaise
HA
Fever
Arthralgias
Uticaria
Weight loss
Jaundice
Hepatomegaly
Splenomegaly
Pruritus
Dark urine
Bilirubinuria
Light stools
Fatigue
Chronic
Malaise
Easy fatigability
Hepatomegaly
12
Phases
Preicteric
Prodromal
Icteric
Jaundice
Posticteric
Convalescent
13
Hepatitis A
Fecal/oral
15-50d
S/S
Light stools
Dark urine
Fatigue
Fever
Jaundice
Labs
Vaccine
IgG
Prevention
14
Hepatitis B
Percutaneous/permucosal
Sexual contact
Perinatal
45-180d
S/S
30% asymptomatic
Flu
Light stools
Dark urine
Fatigue
Fever
Jaundice
Labs
Prevention
Vaccine
IgG
Safe sex
No sharing of razors,
toothbrushes, needles
Chronicity
Antivirals
15
16
Hepatitis C
Percutnaeous/mucosal
Sexual contact
Perinatal
14-180d
S/S
80% asymptomatic
HBV
Labs
Prevention
Safe sex
No sharing of razors,
toothbrushes, needles
Chronicity
Interferon
antivirals
17
18
Hepatitis D
HBV
2-26wk
Labs
Interferon
HBV vaccine
S/S
HBV
19
Hepatitis E
Fecal/oral
Contaminated water
Poor sanitation
15-64d
Labs
S/S
HBV
No vaccine
20
Diagnostics
LFT
ALP
Serum bilirubin
Liver biopsy
Antigen specific
21
Treatment
Diet
Fluid management
Bed rest
Drug therapy
Cirrhosis
23
Pathophysiology
destruction of liver cells, fibrosis and nodule
formation restricting blood and bile flow
Normal hepatic blood pressure is near zero.
Restriction of blood flow in liver dysfunction causes
hypertension, and blood will attempt to find other
pathways, bypass liver
Results in significant impairment of liver function
80% destroyed before signs and symptoms
Liver can regenerate itself if good nutrition, rest,
and no alcohol
Types of Cirrhosis
Classified by risk factors
Post necrotic
Hepatitis
Alcoholic Cirrhosis
Laennecs
metabolic changes in liver, particularly fat
Biliary
obstructive
Cardiac
right side heart failure
Drug induced
INH, rifampin, Tylenol
25
Liver enlarged
Dull pain RUQ
Weakness
Anorexia
Skin
Sclera
Portal hypertension
Splenomegaly
Ascites
Esophageal varices
Hepatic encephalopathy
Hepatorenal Syndrome
Liver failure
26
28
Jaundice
Excess bilirubin
Hepatocellular
Cirrhosis
Obstructive
Hemolytic
Excessive destruction of RBCs
Transfusion reaction
Autoimmune
Faulty hemoglobin
Sickle cell
29
Diagnostics
LFT
CBC
Coags
Bilirubin
Albumin
Esophagoscopy
Liver biopsy
*See Table 44.15
30
Liver Biopsy
3 types
Needle
Laparoscopic
Transvenous
Catheter
Blood clotting problems
Excess fluid
Complications
Liver Biopsy
minimum of 2 hrs
flat 12-14 hrs
34
Nursing Assessment
LOC
Reflexes
Hyperreflexia
Pupils
Orientation
Sensory/motor
Asterexis
http://www.youtube.com/watch?v=pAOWjYo-sX4
Coordination
Dysmetria
Fluid/electrolytes
Acid/base imbalances
35
Treatment
Diet
Sodium restriction
High carbs
Mod fat
75-100gm protein
Fluid management
Drug therapy
Diuretics
Laxatives
Anti-infective agents
Surgical/medical interventions
Major Complications of
Cirrhosis
Portal hypertension
Variceal bleeding
Ascites
Spontaneous bacterial peritonitis
Splenomegaly
Hepatorenal syndrome
Hepatic encephalopathy
37
Portal Hypertension
Arteriovenous shunting
Marked ascites
Caput medusae
Dilated abdominal veins
Esophageal varices
Hemorrhoids
Hyperslenism
anemia
Neutropenia
Thrombocytopenia
38
Surgical/Medical Interventions
Paracentesis
Gastric lavage
Balloon tamponade
Schlerotherapy
Banding
TIPS (transjugular intrahepatic portosystemic
shunt)
Liver transplant
39
Ascites
Sodium restriction
Bedrest initially
Diuretics
Spironolactone
Lasix
HCTZ
Fluid removal
Paracentesis
Peritoneovenous Shunt
Ascites
Caput medusae
41
Paracentesis
42
43
Esophageal varices
Collateral vessels
Complex of swollen, enlarged veins
Portal hypertension
Bleeding
LIFE-THREATENING
44
Sclerotherapy
sclerosant solution (ethanolamine oleate or sodium tetradecyl sulphate)
Complications
fever, dysphagia and chest pain, ulceration, stricture, and (rarely)
perforation.
Band ligation
Fewer treatment sessions and complications than sclerotherapy.
Minnesota
Tube
SengstakenBlakemore
tube has only 3
lumens
**Respiratory
assessment**
50
Hepatic encephalopathy
Neuropsychiatric manifestation
Decreased liver detoxification>>>
Increased ammonia
Terminal complication
Asterixis
51
Treatment HE
Reduce ammonia
Lactulose
Neomycin sulfate
Cathartics
Enemas
Liver transplantation
52
Hepatorenal syndrome
Portal HTN + liver decompensation
Systemic vasodilation
Decreased arterial BF
Renal vasoconstriction
Liver transplantation
Liver Transplant
54
Liver Transplant
Infection
immunosuppression
Cancer
56
Patient Teaching
Therapeutic communication
Diet*
Exercise
Lifestyle modifications
Drugs
Follow-up
Resources
57
Donors
Live donor
Liver regenerates
5 years
Review
1. Pathophysiology
1. Cirrhosis
2. Portal hyperetension
3. Liver failure
1. Encephalopathy
2. Hepato-renal
syndrome
2. Signs & Symptoms
3. Treatment
4. Nsg. Care
5. Complications